Tuomas Kiviniemi
MD, PhD, FESC
tuoski@utu.fi |
Cardiology; Clinical trials; Atrial fibrillation; Coronary artery disease; Percutaneous coronary intervention; Wearables; Anticoagulation; Bleeding; Translational research
Professor of cardiology, PI in CAREFIB and LAA-CLOSURE
Tuomas Kiviniemi, MD, PhD, FESC, is Professor of Cardiology at the University of Turku and Chief Physician at the Heart Center, Turku University Hospital. His clinical and academic work focuses on interventional cardiology, atrial fibrillation, and cardiovascular risk in patients undergoing cardiac procedures. He also serves as President of the Finnish Cardiac Society for the 2024–2026 term, contributing nationally to cardiovascular care development and professional education.
Professor Kiviniemi completed his medical and doctoral degrees at the University of Turku and later broadened his research expertise during a research fellowship at Brigham and Women’s Hospital, Harvard Medical School. His research integrates clinical trials, biomarker studies, translational science, and outcome research in percutaneous and surgical cardiac interventions. He leads the multidisciplinary CAREFIB Consortium, which encompasses several major investigator-initiated studies, including CAREBANK, CAREiCON and the LAA-CLOSURE randomized trial program investigating stroke prevention strategies in atrial fibrillation.
His scientific output includes peer-reviewed publications, book chapters, trial leadership roles, and long-term collaborations with computational medicine, imaging, and device-innovation groups.
In addition to his academic duties, Professor Kiviniemi is a frequently invited expert in the European Society of Cardiology community, contributing as an abstract reviewer, session chair, and presenter in acute coronary syndromes and interventional cardiology themes.
At the national level, he has served as a long-standing member and chair within the Finnish Cardiac Society, holding multiple leadership and editorial roles. As President of the Society 2024-2026, he advanced cardiovascular education, guidelines, and professional collaboration across Finland.
Professor Kiviniemi’s current research interests span atrial fibrillation detection technologies, outcomes after cardiac surgery, advanced imaging, and digital health solutions. His work continues to bridge clinical cardiology with engineering, data science, and translational discovery, supporting the University of Turku’s strategic strengths in cardiovascular medicine.
At the University of Turku, Professor Kiviniemi is actively involved in supervising doctoral trainees in cardiology, and he has mentored more than ten completed PhD theses. His teaching activities also include specialist training and contributions to national cardiology textbooks.
- Antikoagulaatiohoito eteisvärinässä (2024) Kardiologia Raatikainen, Pekka; Kiviniemi, Tuomas; Junttila, Juhani
- Association between aortic calcification and cytokine levels in patients with peripheral artery disease (2024)
- Clinical and Translational Science
- Classification of the Urgency of the Procedure and Outcome of Acute Type A Aortic Dissection (2024)
- American Journal of Cardiology
- Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease (2024)
- Scientific Reports
- Distinct circulating cytokine levels in patients with angiography-proven coronary artery disease compared to disease-free controls (2024)
- International journal of cardiology : Cardiovascular risk and prevention
- Ennusteen arviointi sepelvaltimotautikohtauksen jälkeen (2024) Kardiologia Mäkikallio, Timo; Kiviniemi, Tuomas; Laine, Mika
- Eteisvärinään liittyvän tukosvaaran arviointi ja tukosten esto (2024) Kardiologia Raatikainen, Pekka; Kiviniemi, Tuomas; Junttila, Juhani
- Eteisvärinän antikoagulaatiohoito sepelvaltimotautipotilailla (2024) Kardiologia Kiviniemi, Tuomas; Lassila, Riitta
- Ferric carboxymaltose in reducing blood transfusions and infections after cardiac surgery (2024)
- JTCVS Open
- Fibrillatory wave amplitude and thromboembolic risk in non-anticoagulated patients with atrial fibrillation (2024)
- Annals of Medicine
- Genetics, transcriptomics, metagenomics, and metabolomics in the pathogenesis and prediction of atrial fibrillation (2024)
- European Heart Journal Supplements
- In Reply to the Letter to the Editor Regarding "Positive Correlation Between Thoracic Aortic Diameter and Intracranial Aneurysm Size-An Observational Cohort Study" (2024)
- World Neurosurgery
- Ischemic Stroke Temporally Associated With New-Onset Atrial Fibrillation: A Population-Based Registry-Linkage Study (2024)
- Stroke
- Major bleeding complications and antithrombotic treatment after isolated surgical bioprosthetic aortic valve replacement (2024)
- European Heart Journal
- Munuaissairauksien, reumasairauksien ja uniapnean yhteydet sydänsairauksiin: reumasairaudet (2024) Kardiologia Kiviniemi, Tuomas
- Näin otat hyytymisenestolääkityksen huomioon toimenpiteessä (2024)
- Lääkärilehti
- Novel electrocardiographic classification for stroke prediction in atrial fibrillation patients undergoing cardioversion (2024)
- Heart Rhythm
- Performance of D-dimer, cardiac troponin T, C-reactive protein, and NT-proBNP in prediction of long-term mortality in patients with suspected pulmonary embolism (2024)
- European heart journal open
- Positive correlation between thoracic aortic diameter and intracranial aneurysm size: An observational cohort study (2024)
- World Neurosurgery
- Prolonged Systemic Inflammatory Response Syndrome After Cardiac Surgery (2024)
- Journal of Cardiothoracic and Vascular Anesthesia



